Radiotracers for imaging of Parkinson's disease
- 1 March 2019
- journal article
- review article
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 166, 75-89
Abstract
No abstract availableKeywords
This publication has 153 references indexed in Scilit:
- The Halogen Bond in the Design of Functional Supramolecular Materials: Recent AdvancesAccounts of Chemical Research, 2013
- Extrastriatal dopaminergic abnormalities of DA homeostasis in Parkinson's patients with medication-induced pathological gambling: A [11C] FLB-457 and PET studyNeurobiology of Disease, 2012
- Neurotoxin-induced ER stress in mouse dopaminergic neurons involves downregulation of TRPC1 and inhibition of AKT/mTOR signalingJournal of Clinical Investigation, 2012
- Evaluation of the PBR/TSPO Radioligand [18F]DPA-714 in a Rat Model of Focal Cerebral IschemiaJournal of Cerebral Blood Flow & Metabolism, 2009
- PET radiotracers: crossing the blood–brain barrier and surviving metabolismTrends in Pharmacological Sciences, 2009
- RetromerCurrent Opinion in Cell Biology, 2008
- Cognitive impairment in Parkinson's diseaseJournal of Neurology, Neurosurgery & Psychiatry, 2007
- Diagnosis and treatment of Parkinson disease: molecules to medicineJournal of Clinical Investigation, 2006
- Imaging of dopamine transporters in humans with technetium-99m TRODAT 1European Journal of Nuclear Medicine and Molecular Imaging, 1996
- AGEING AND PARKINSON'S DISEASE: SUBSTANTIA NIGRA REGIONAL SELECTIVITYBrain, 1991